Site Activity
This page provides a monthly listing of publication activity on the Medical Policy Portal including Policy Notifications, New Policies, Updated Policies, Coding Updates, Reissued Policies, and Archived Policies. To view publication activity from prior months, select Past Site Activity.

Past Site Activity
 
                                                                                                        

Notifications
The following Independence Blue Cross Medicare Advantage policies have been posted prior to their effective date.
MA08.058c, Blinatumomab (Blincyto®)
Notification: 07/10/2018 | Effective: 10/08/2018 | Posted: 07/10/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA08.097, Triamcinolone acetonide ER Injectable (Zilretta)
Notification: 07/20/2018 ( Revised: 08/13/2018) | Effective: 08/20/2018 | Posted: 07/20/2018
Type of policy change: This is a new policy.

MA11.105e, Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of Glaucoma
Notification: 07/25/2018 | Effective: 10/22/2018 | Posted: 07/25/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria; General Description, Guidelines, or Informational Update


New Policies
The following Medicare Advantage policies have been newly developed to communicate coverage and/or reimbursement positions, reporting requirements, and other processes and procedures for doing business with Independence Blue Cross.
MA08.096, ibalizumab-uiyk (Trogarzo™)
Effective: 07/02/2018 | Posted: 07/02/2018
Type of policy change: This is a new policy.

MA08.098, Tildrakizumab-asmn (Ilumya™)
Effective: 07/16/2018 | Posted: 07/16/2018
Type of policy change: This is a new policy.


Updated Policies
The following Medicare Advantage policies have been reviewed and updated to communicate current coverage and/or reimbursement positions, reporting requirements, and other procedures for doing business with Independence Blue Cross.
MA07.009f, Routine Foot Care for Certain Medical Conditions
Effective: 07/02/2018 | Posted: 07/02/2018
Type of policy change: Medical Necessity Criteria; Medical Coding

MA05.016d, Home Prothrombin Time Monitoring
Notification: 04/03/2018 | Effective: 07/02/2018 | Posted: 07/02/2018
Type of policy change: Medical Coding

MA11.014d, Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic Toe Nails
Effective: 07/02/2018 | Posted: 07/02/2018
Type of policy change: Medical Necessity Criteria; Medical Coding

MA00.005n, Experimental/Investigational Services
Effective: 07/01/2018 | Posted: 07/02/2018
Type of policy change: Medical Coding

MA08.037d, Bortezomib (Bortezomib for Injection, Velcade®)
Notification: 06/08/2018 | Effective: 07/09/2018 | Posted: 07/09/2018
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA10.008b, Supervised Exercise Therapy (SET) for Symptomatic Peripheral Artery Disease (PAD)
Effective: 07/16/2018 | Posted: 07/16/2018
Type of policy change: Coverage and/or Reimbursement Position

MA07.033d, Nerve Conduction Studies (NCS) and Related Electrodiagnostic Studies
Effective: 07/23/2018 | Posted: 07/23/2018
Type of policy change: Medical Coding

MA00.005o, Experimental/Investigational Services
Effective: 07/23/2018 | Posted: 07/23/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Coding

MA07.050d, Electromyography (EMG) Studies: Needle EMG, Surface EMG (SEMG)
Effective: 07/23/2018 | Posted: 07/23/2018
Type of policy change: Medical Coding

MA07.051e, Intraoperative Neurophysiological Testing
Effective: 07/23/2018 | Posted: 07/23/2018
Type of policy change: Medical Coding

MA07.020a, Photography, including Documentation and Record-Keeping Photography, Whole Body Integumentary Photography, Dermoscopy, and Dermatoscopy
Effective: 07/30/2018 | Posted: 07/30/2018
Type of policy change: General Description, Guidelines, or Informational Update

MA08.093c, Chimeric Antigen Receptor (CAR) Therapy
Effective: 07/30/2018 | Posted: 07/30/2018
Type of policy change: Medical Necessity Criteria; Medical Coding; General Description, Guidelines, or Informational Update

MA07.026a, Ambulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring
Effective: 07/30/2018 | Posted: 07/30/2018
Type of policy change: Medical Coding; General Description, Guidelines, or Informational Update

MA05.053f, Implantable and External Infusion Pumps
Notification: 06/27/2018 | Effective: 07/30/2018 | Posted: 07/30/2018
Type of policy change: Coverage and/or Reimbursement Position; Medical Necessity Criteria


Reissue Policies
The following Medicare Advantage policies have been reviewed, and no substantive changes were made.
MA11.016a, Prostate Mapping Biopsy
Reissue Effective: 07/03/2018 | Reissue Posted: 07/03/2018

MA02.002, Private Duty Nursing
Reissue Effective: 07/03/2018 | Reissue Posted: 07/03/2018

MA05.045a, Compression Garments
Reissue Effective: 07/03/2018 | Reissue Posted: 07/03/2018

MA08.088b, Ocrelizumab (Ocrevus™)
Reissue Effective: 07/03/2018 | Reissue Posted: 07/05/2018

MA11.007, Islet Cell Transplantation
Reissue Effective: 07/18/18 | Reissue Posted: 07/19/2018

MA11.049c, Bone-Anchored (Osseointegrated) Hearing Aids and Implantable Middle Ear Hearing Aids
Reissue Effective: 07/18/2018 | Reissue Posted: 07/19/2018

MA07.006a, Fecal Microbiota Transplantation (FMT)
Reissue Effective: 07/18/2018 | Reissue Posted: 07/19/2018


Coding Update
The following Medicare Advantage policies have been reviewed and updated to add new and revised medical codes (e.g., ICD-9 and ICD-10 diagnosis codes; CPT® and HCPCS codes; revenue codes) and/or remove terminated medical codes.
MA06.017m, Molecular Diagnostics
Effective: 07/01/2018 | Posted: 07/03/2018

MA06.025f, Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
Effective: 07/01/2018 | Posted: 07/03/2018

(Not Categorized)
MA08.007k, Medicare Part B vs. Part D Crossover Drugs
Notification: 06/27/2018 | Effective: 07/30/2018 | Posted: 07/30/2018










Connect with Us        


© 2017 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.